|
Volumn 15, Issue 2, 2001, Pages 289-291
|
Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
DNA FRAGMENT;
DOUBLE STRANDED DNA;
GLUTATHIONE TRANSFERASE;
IMMUNOGLOBULIN HEAVY CHAIN;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
MICROSATELLITE DNA;
PROTEIN KINASE;
PROTEIN P16;
PROTEIN P53;
TUMOR MARKER;
ARTICLE;
BLOOD ANALYSIS;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DNA DAMAGE;
DNA DETERMINATION;
FOLLOW UP;
GENE MUTATION;
GENETIC ANALYSIS;
HETEROZYGOSITY LOSS;
HUMAN;
LUNG SMALL CELL CANCER;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MINIMAL RESIDUAL DISEASE;
MOLECULAR GENETICS;
MUTATION RATE;
ONCOGENE K RAS;
ONCOGENE N RAS;
PANCREAS CANCER;
PATIENT MONITORING;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGNOSIS;
RADIOIMMUNOASSAY;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR GENE;
|
EID: 0035102255
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402016 Document Type: Article |
Times cited : (30)
|
References (17)
|